leadf
logo-loader
NASDAQ:ACAD

ACADIA Pharmaceuticals Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$2.68 billion
Price
16.70 USD
Change
3.60%
52 weeks high
57.45
52 weeks low
15.68

In brief

ACADIA Pharmaceuticals (NASDAQ: ACAD) is a biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. We have a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson's disease psychosis.